Tuberculosis: open trials in Brazil

• NCT06497465

  Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

  Trial Treatment · Phase 3 · Johns Hopkins University

  Instituto Tropical de Doenças Infecciosas Manaus, Manaus · CePClin - Center for Studies and Research in Infectious Diseases Ltda, Natal · Hospital Geral de Nova Iguaçu, Rio de Janeiro · FIOCruz, Rio de Janeiro · Universidade Federal da Bahia, Salvador

  Registry updated 2026-09-11

• NCT07595042

  A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

  Trial Treatment · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)

  Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS (Site # 12101), Rio de Janeiro · Instituto de Pesquisas em AIDS do Rio Grande do Sul - IPARGS CRS (Site # 12201), Rio Grande

  Registry updated 2026-08-19

• NCT07731672

  Incidence of Tuberculosis in Patients With Autoimmune Rheumatic Diseases

  Trial Treatment · University of Sao Paulo General Hospital

  Rheumatology Division, Faculdade de Medicina da USP, São Paulo, SP, São Paulo

  Registry updated 2026-08-18

• NCT05383742

  Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

  Trial Treatment · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)

  Hospital Nossa Senhora da Conceicao CRS (Site ID: 12201), Porto Alegre · Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS (Site ID# 12101), Rio de Janeiro

  Registry updated 2026-06-02

• NCT06498414

  Shorter and Safer Treatment Regimens for Latent TB

  Trial Treatment · Phase 2/3 · McGill University Health Centre/Research Institute of the McGill University Health Centre

  Manaus, Manaus

  Registry updated 2026-05-11

• NCT05590455

  Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

  Trial Treatment · Phase 2 · ANRS, Emerging Infectious Diseases

  Laboratory of clinical research on STD/AIDS - IPEC/FIOCRUZ, Rio de Janeiro

  Registry updated 2025-12-15

• NCT06127641

  Rehabilitation of People With Post-tuberculosis Lung Disease

  Trial Treatment · Centro Universitário Augusto Motta

  Centro Universitário Augusto Motta, Rio de Janeiro · Agnaldo José Lopes, Rio de Janeiro

  Registry updated 2023-11-13

All Tuberculosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error